On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

VPS45

vacuolar protein sorting 45 homolog

Chromosome 1q21.2 Autosomal recessive HGNC:14579 Tier C
VPS45 1q21.2 p arm q arm 1

VPS45 is located on the long (q) arm of chromosome 1, at band 1q21.2. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 1 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

VPS45 (vacuolar protein sorting 45 homolog) is a gene that encodes a protein essential for intracellular membrane trafficking, a process by which cells move proteins and other molecules between different compartments. The VPS45 protein acts as a regulatory component in the machinery that controls vesicle fusion, ensuring that cellular cargo reaches the correct destination. This function is particularly important in immune cells and platelets, where precise delivery of proteins to specific locations is critical for proper function.

Pathogenic variants in VPS45 follow an autosomal recessive inheritance pattern, meaning individuals require variants in both gene copies to develop associated conditions. The disorders linked to VPS45 dysfunction typically present in early childhood with severe immunodeficiency, bleeding problems, and impaired bone marrow function.

What the gene does

The VPS45 protein serves as a molecular regulator of SNARE-mediated membrane fusion, a fundamental process that allows transport vesicles to merge with their target compartments. Within cells, proteins and other molecules are packaged into membrane-bound vesicles that must fuse with the correct destination membrane to deliver their contents. VPS45 binds to syntaxin proteins, which are key components of the SNARE complex that drives membrane fusion events.

By controlling when and where these fusion events occur, VPS45 ensures that newly synthesised proteins reach appropriate locations such as the cell surface, secretory granules, or degradative compartments. This regulation is particularly crucial in haematopoietic cells, where proper trafficking determines whether immune cells can release antimicrobial compounds, whether platelets can form functional storage granules, and whether cells can present antigens to activate immune responses. Loss of VPS45 function disrupts these trafficking pathways, resulting in cells that cannot properly organise their internal compartments or respond effectively to external signals.

Video: Genetics 101

Chromosome location

VPS45 is located on the long arm of chromosome 1 at position 21.2 (1q21.2). This chromosomal region contains multiple genes and has been associated with genomic variation in various populations. The gene spans approximately 72 kilobases of genomic DNA and contains 23 exons that encode the VPS45 protein.

Protein structure

Domain architecture has not been experimentally characterised in detail for this protein.

Key variants

Pathogenic variants in VPS45 are rare but typically result in severe loss of protein function. Most reported variants are either nonsense mutations that introduce premature stop codons or missense changes that disrupt critical protein interactions. Because the condition follows autosomal recessive inheritance, affected individuals carry pathogenic variants on both chromosome copies. The severity of clinical presentation can vary depending on whether variants completely abolish protein function or permit residual activity.

No pathogenic or likely-pathogenic ClinVar variants recorded yet for this gene.

Associated conditions

Pathogenic variants in VPS45 cause a severe combined immunodeficiency syndrome characterised by recurrent infections, bleeding disorders, and bone marrow dysfunction. Affected individuals typically present in infancy with severe bacterial and fungal infections resulting from impaired neutrophil function. The condition also features thrombocytopenia (low platelet counts) and platelet dysfunction, leading to excessive bruising and bleeding. Neutropenia (low neutrophil counts) is common, and some individuals develop anaemia. The combination of immune and haematological features reflects the critical role of VPS45 in multiple blood cell lineages.

No condition pages are linked to this gene yet. This does not mean it has no associated conditions.

Inheritance pattern

Conditions caused by pathogenic VPS45 variants typically follow autosomal recessive inheritance.

♀ Carrier parent 1 altered copy ♂ Carrier parent 1 altered copy Affected Carrier Carrier Unaffected Affected Carrier Unaffected Circles = females · Squares = males

When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.

Carrier frequency by population How common is heterozygous VPS45 carrier status across ancestry groups?

UK clinical status

VPS45 appears on several NHS Genomic Medicine Service gene panels, reflecting its role in immunodeficiency and blood disorders. The gene is listed on the Primary immunodeficiency or monogenic inflammatory bowel disease panel (R15), the Cytopenia - NOT Fanconi anaemia panel (R91), and the broader Cytopenias and congenital anaemias panel. It also appears on the COVID-19 research panel. All listings have green classification status, indicating sufficient evidence for clinical use in relevant diagnostic pathways.

Frequently asked questions

How is VPS45-related immunodeficiency inherited?

VPS45-related conditions follow autosomal recessive inheritance. An individual must inherit a pathogenic variant from both parents to be affected. Parents who each carry one variant typically show no symptoms but have a 25% chance with each pregnancy of having an affected child.

What symptoms typically appear with VPS45 variants?

Affected individuals usually present in early childhood with recurrent severe infections, excessive bleeding or bruising, and low blood cell counts. The combination of immune deficiency and platelet problems distinguishes this condition from many other primary immunodeficiencies.

Can VPS45 variants be detected through genetic testing?

Yes, pathogenic variants in VPS45 can be identified through genetic sequencing, particularly in individuals presenting with combined immunodeficiency and bleeding disorders. Testing is typically arranged through clinical genetics services for individuals with suggestive clinical features.

Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 17 April 2026. Content compiled from HGNC · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .